Hyloris Pharmaceuticals SA (EBR:HYL)
6.10
-0.10 (-1.61%)
Oct 8, 2025, 4:46 PM CET
Hyloris Pharmaceuticals Revenue
Hyloris Pharmaceuticals had revenue of 3.34M EUR in the half year ending June 30, 2025, with 74.54% growth. This brings the company's revenue in the last twelve months to 8.46M, up 30.42% year-over-year. In the year 2024, Hyloris Pharmaceuticals had annual revenue of 9.76M with 159.64% growth.
Revenue (ttm)
8.46M
Revenue Growth
+30.42%
P/S Ratio
20.52
Revenue / Employee
169.18K
Employees
49
Market Cap
173.60M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.76M | 6.00M | 159.64% |
Dec 31, 2023 | 3.76M | 1.37M | 57.48% |
Dec 31, 2022 | 2.39M | -709.00K | -22.90% |
Dec 31, 2021 | 3.10M | 2.92M | 1,669.14% |
Dec 31, 2020 | 175.00K | 84.00K | 92.31% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UCB SA | 6.85B |
argenx SE | 2.66B |
Financière de Tubize | 13.26K |
Fagron NV | 918.75M |
Ion Beam Applications | 585.76M |
Onward Medical | 2.72M |
Nyxoah | 4.93M |
Sequana Medical NV | 105.50K |